Rejected at 3:25 a.m. Nov, 01, 2023 ] by Ahmed7
Author: willolive22
Related Note: 1484768430296
Rationale for change

missed the UWorld question because it didnt explain what the GABA actually did. UW is looking for 'increased frequency' of chloride channel opening
Source: UWorld - Step 1 1443

Rejection reason

comments

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::03_Benzodiazepines-Function #AK_Step2_v12::#CMS::Psychiatry::Form_07 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::02_Anxiolytic_and_Hypnotic_Drugs #AK_Step2_v12::#UWorld::Step::19662 #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::06_Sedative-Hypnotics::01_Benzodiazepines_&_Flumazenil #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#NBME::Free120::2024 #AK_Step1_v12::#B&B::16_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters::Extra #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::05_Benzodiazepines #AK_Step1_v12::#UWorld::Step::937 #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::10_Multiple_Sclerosis::Extra #AK_Step1_v12::#UWorld::Step::1443 #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::09_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment,_Complications/Status_Epilepticus #AK_Step1_v12::#UWorld::COMLEX::24554 #AK_Step1_v12::#OME::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Step1_v12::#AMBOSS::Bjazck #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::10_Febrile_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment) #AK_Other::Only_Step_1 #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::05_Benzodiazepines #AK_Step1_v12::#NBME::30 #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#UWorld::Step::11665 #AK_Step1_v12::#B&B::01_Anesthesia::01_General::02_Intravenous_Anesthetics #AK_Step2_v12::#CMS::Psychiatry::Form_05 #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::05_Status_Epilepticus #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::03_Benzodiazepines #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::05_Anticonvulsants_II #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::06_Antiepileptic_Medications #AK_Step1_v12::#UWorld::COMLEX::24049